NEDD4L and hypertensive disorder: It is likely that use of putative compounds that aim to enhance ENaC internalization or Nedd4-2 activity would be more effective towards other forms of hypertension and not Liddle syndrome, since the latter carries mutations that already inhibit ENaC internalization and are insensitive to Nedd4-2.